Effect of antisense oligodeoxynucleotide of vascular endothelial growth factor C on lymphangiogenesis and angiogenesis of pancreatic cancer

Journal of Huazhong University of Science and Technology - Medical Science

Volumn 27, Issue 1, 2007, Pages 51-53

  Li, Kai ^a   Tao, Jing ^a   Li, Tao ^b   Yu, Zhou ^a   Yang, Zhiyong ^a   Wu, Heshui ^a   Xiong, Jiongxin ^a   Wang, Chunyou ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b Wuhan Children's Hospital   (China)

Author keywords

Angiogenesis; Gene therapy; Lymphangiogenesis; Pancreatic cancer; Vascular endothelial growth factor C

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; BLOOD CLOTTING FACTOR 8; VASCULOTROPIN C; VASCULOTROPIN RECEPTOR 3;

ANIMAL; ARTICLE; BLOOD; DISEASE MODEL; DRUG ADMINISTRATION; DRUG ANTAGONISM; DRUG EFFECT; DRUG SCREENING; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE THERAPY; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPHANGIOGENESIS; METABOLISM; METHODOLOGY; MICROCIRCULATION; MOUSE; NEOVASCULARIZATION (PATHOLOGY); PANCREAS TUMOR; PATHOLOGY; RANDOMIZATION; TUMOR CELL LINE; VASCULARIZATION;

ANIMALS; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; DRUG ADMINISTRATION SCHEDULE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FACTOR VIII; GENE THERAPY; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHANGIOGENESIS; MICE; MICROCIRCULATION; NEOVASCULARIZATION, PATHOLOGIC; OLIGONUCLEOTIDES, ANTISENSE; PANCREATIC NEOPLASMS; RANDOM ALLOCATION; VASCULAR ENDOTHELIAL GROWTH FACTOR C; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-3; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 33947362074     PISSN: 16720733     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11596-007-0115-0     Document Type: Article

References (8)

1. Tang R F, Itakura J, Aikawa T et al. Overexpression of lymphangiogenic growth factor VEGF-C in human pancreatic cancer. Pancreas, 2001,22(3):285-292
2. Skobe M, Hamberg L M, Alitalo K et al. Concurrent induction of lymphangiogenesis, angiogenesis, and macrophage recruitment by vascular endothelial growth factor-C in melanoma. Am J Pathol, 2001,159:893-903
3. Weidner N. Intratumor microvessel density as a prognostic factor in cancer. Am J Pathol, 1995,147:9-19
4. Li K, Tao J, Wang C Y. Expression of vascular endothelial growth factor C and its correlation with lymphangiogenesis in pancreatic carcinoma. Chin J Exp Surg (Chinese), 2006,23:16-17
5. Berger A C, Watson J C, Rose E A et al. The meastatic/examined lymph node ratio is an important progonostic factor after pancreaticoduodenectomy for pancreatic adenocarcinoma. Am Surg, 2004,70:235-240
6. Joukov V, Sorsa R, Alitalo K et al. Proteolytic processing regulates receptor specificity and activity of VEGF-C. EMBO, 1997,16(13):3898-3911
7. Hotz H G, Hines O J, Masood R et al. VEGF antisense therapy inhibits tumor growth and improves survival in experimental pancreatic cancer. Surgery, 2005, 137(2): 192-199
8. Dass C R1. Liposome-mediated delivery of oligodeoxynucleotides in vivo. Drug Delivery, 2002,9(3): 169-180